Guiard Bruno P, Froger Nicolas, Hamon Michel, Gardier Alain M, Lanfumey Laurence
INSERM/UPMC, Neuropsychopharmacologie, CHU Pitié-Salpêtrière, Paris, France.
J Neurochem. 2005 Dec;95(6):1713-23. doi: 10.1111/j.1471-4159.2005.03488.x. Epub 2005 Oct 7.
Antagonists at NK1 substance P receptors have demonstrated similar antidepressant properties in both animal paradigms and in human as selective serotonin reuptake inhibitors (SSRIs) that induce desensitization of 5-HT 1A autoreceptors within the dorsal raphe nucleus (DRN). We investigated whether this receptor adaptation also occurs upon NK1 receptor blockade. C57B/L6J mice were treated for 21 days with the selective NK1 receptor antagonist GR 205171 (10 mg/kg daily) through subcutaneously implanted osmotic mini pumps, and DRN 5-HT 1A autoreceptor functioning was assessed using various approaches. Recording of DRN serotonergic neurons in brainstem slices showed that GR 205171 treatment reduced (by approximately 1.5 fold) the potency of the 5-HT 1A receptor agonist, ipsapirone, to inhibit cell firing. In parallel, the 5-HT 1A autoreceptor-mediated [35S]GTP-gamma-S binding induced by 5-carboxamidotryptamine onto the DRN in brainstem sections was significantly decreased in GR 205171-treated mice. In vivo microdialysis showed that the cortical 5-HT overflow caused by acute injection of the SSRI paroxetine (1 mg/kg) was twice as high in GR 205171-treated as in vehicle-treated controls. In the DRN, basal 5-HT outflow was significantly enhanced by GR 205171 treatment. These data supported the hypothesis that chronic NK1 receptor blockade induces a functional desensitization of 5-HT 1A autoreceptors similar to that observed with SSRIs.
NK1 速激肽受体拮抗剂在动物模型和人类中均表现出与选择性 5-羟色胺再摄取抑制剂(SSRI)相似的抗抑郁特性,后者可诱导中缝背核(DRN)内 5-HT 1A 自身受体脱敏。我们研究了 NK1 受体阻断后是否也会发生这种受体适应性变化。通过皮下植入渗透微型泵,用选择性 NK1 受体拮抗剂 GR 205171(每日 10 mg/kg)对 C57B/L6J 小鼠进行 21 天治疗,并使用多种方法评估 DRN 5-HT 1A 自身受体功能。脑干切片中 DRN 5-羟色胺能神经元的记录显示,GR 205171 治疗降低了(约 1.5 倍)5-HT 1A 受体激动剂 ipsapirone 抑制细胞放电的效力。同时,在 GR 205171 治疗的小鼠中,5-羧酰胺色胺在脑干切片中诱导的 DRN 上 5-HT 1A 自身受体介导的 [35S]GTP-γ-S 结合显著降低。体内微透析显示,急性注射 SSRI 帕罗西汀(1 mg/kg)引起的皮质 5-羟色胺溢出在 GR 205171 治疗组中是溶剂对照组的两倍。在 DRN 中,GR 205171 治疗显著增强了基础 5-羟色胺流出。这些数据支持了以下假设:慢性 NK1 受体阻断会诱导 5-HT 1A 自身受体功能脱敏,类似于 SSRI 所观察到的情况。